Hepatorenal syndrome

Common Name(s)

Hepatorenal syndrome

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatorenal syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Hepatorenal syndrome" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Hepatorenal syndrome" returned 71 free, full-text research articles on human participants. First 3 results:

A Case of Hepatorenal Syndrome and Abdominal Compartment Syndrome with High Renal Congestion.
 

Author(s): Hiroteru Kamimura, Takayuki Watanabe, Tomoyuki Sugano, Nao Nakajima, Junji Yokoyama, Kenya Kamimura, Atsunori Tsuchiya, Masaaki Takamura, Hirokazu Kawai, Takashi Kato, Gen Watanabe, Satoshi Yamagiwa, Shuji Terai

Journal:

 

BACKGROUND Hepatorenal syndrome (HRS) is a reversible renal impairment that occurs in patients with acute liver failure and advanced liver cirrhosis. HRS is due to a renal vasoconstriction that results from extreme vasodilatation. It is therefore a functional disorder, not associated ...

Last Updated: 31 Dec 1969

Go To URL
Hepatorenal Syndrome In Patients With Cirrhosis Of Liver According To 2007 International Ascites Club Criteria.
 

Author(s): Naresh Kumar Seetlani, Abdul Rauf Memon, Fehmeen Iftikhar, Asif Ali, Pyar Ali Fazel

Journal: J Ayub Med Coll Abbottabad. ;28(3):578-581.

 

Heptorenal syndrome is a complication of cirrhosis of liver and is characterized by progressive renal failure. This study was done to determine the frequency of hepatorenal syndrome according to 2007 international ascites club criteria among patients of cirrhosis attending Medical ...

Last Updated: 31 Dec 1969

Go To URL
Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.
 

Author(s): A J Sanyal, T D Boyer, R T Frederick, F Wong, L Rossaro, V Araya, H E Vargas, K R Reddy, S C Pappas, P Teuber, S Escalante, K Jamil

Journal: Aliment. Pharmacol. Ther.. 2017 06;45(11):1390-1402.

 

The goal of hepatorenal syndrome type 1 (HRS-1) treatment is to improve renal function. Terlipressin, a synthetic vasopressin analogue, is a systemic vasoconstrictor used for the treatment of HRS-1, where it is available.

Last Updated: 31 Dec 1969

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Hepatorenal syndrome" returned 43 free, full-text review articles on human participants. First 3 results:

Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis.
 

Author(s): Haiqing Wang, Aixiang Liu, Wentao Bo, Xielin Feng, Yong Hu

Journal: Medicine (Baltimore). 2018 Apr;97(16):e0431.

 

Hepatorenal syndrome is a fatal complication of advanced cirrhosis. Terlipressin is the most widely used treatment method, however, the therapy effects remain inconsonant. We aim to systematically assess the safety and efficacy of terlipressin for hepatorenal syndrome.

Last Updated: 31 Dec 1969

Go To URL
Systematic review with meta-analysis: vasoactive drugs for the treatment of hepatorenal syndrome type 1.
 

Author(s): F J Gifford, J R Morling, J A Fallowfield

Journal: Aliment. Pharmacol. Ther.. 2017 03;45(5):593-603.

 

Hepatorenal syndrome type 1 (HRS1) is a functional, rapidly progressive, potentially reversible form of acute kidney injury occurring in patients with cirrhosis. Characterised by intense renal arterial vasoconstriction, it carries a very poor prognosis. There is a significant unmet ...

Last Updated: 31 Dec 1969

Go To URL
 Hepatorenal syndrome: Current concepts related to diagnosis and management.
 

Author(s): Ángelo Zambam de Mattos, Angelo Alves de Mattos, Nahum Méndez-Sánchez

Journal: Ann Hepatol. ;15(4):474-81.

 

 Renal failure in cirrhotic patients is a very severe condition. Hepatorenal syndrome has the worst prognosis among all causes of kidney failure in such patients. Hepatorenal syndrome is diagnosed especially in cirrhotic patients with ascites who develop loss renal function, despite ...

Last Updated: 31 Dec 1969

Go To URL
 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Last Updated: 21 Jun 2017

Go to URL
Norepinephrine Infusion Versus Midodrine & Octreotide in Patients With Hepatorenal Syndrome Type 1.
 

Status: Recruiting

Condition Summary: Renal Impairment in Hepatorenal Syndrome

 

Last Updated: 6 Mar 2018

Go to URL
A Study To Confirm Efficacy and Safety of Terlipressin in HRS Type 1
 

Status: Recruiting

Condition Summary: Hepatorenal Syndrome

 

Last Updated: 9 Aug 2018

Go to URL